SEC CRD #802-129182
Adjuvant is a new type of venture capital firm. We finance the most promising life science technologies for high-burden public health challenges. Adjuvant Capital is a life sciences investment firm focused on global health. We make $10-$25 million investments in ambitious companies. Adjuvant is a life sciences investment fund that backs ambitious companies developing drugs, vaccines, diagnostics, medical devices, and other technologies ...
Chief Compliance
DIRECTOR OF FINANCE AND COMPLIANCE; CHIEF COMPLIANCE OFFICER
📞 (917) 334-0724
🔒 Sign up for free to view key contact information
Sign up free →This profile has not yet been verified by the firm. Information may be incomplete or outdated. Claim this profile to take control of your listing.
Check Size
$300M–$300M
Location
NEW YORK, NY
Claim this profile to complete your information, set investment criteria, and start receiving curated deal flow from sponsors on DEALITHIC.